Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 83.14
-1.78 (-2.10%)
Sep 11, 2026, 3:00 PM CST
SHA:688016 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,275 | 2,003 | 2,171 | 2,967 | 976.89 | 1,243 |
Trading Asset Securities | 906.83 | 100.37 | - | - | - | - |
Cash & Short-Term Investments | 2,182 | 2,103 | 2,171 | 2,967 | 976.89 | 1,243 |
Cash Growth | -1.70% | -3.11% | -26.84% | 203.71% | -21.42% | 18.26% |
Accounts Receivable | 469.43 | 384.46 | 254.04 | 148.09 | 123.99 | 73.2 |
Other Receivables | 4 | 0.41 | 0.84 | 1.03 | 0.86 | 0.71 |
Receivables | 473.43 | 385.25 | 255.12 | 149.37 | 125.27 | 74.05 |
Inventory | 304.38 | 272.3 | 266.4 | 210.89 | 155.97 | 106.92 |
Other Current Assets | 35.49 | 41.43 | 48.04 | 38.06 | 36.2 | 34.42 |
Total Current Assets | 2,996 | 2,802 | 2,740 | 3,365 | 1,294 | 1,459 |
Property, Plant & Equipment | 863.26 | 712.48 | 411.76 | 335.32 | 225.84 | 117.12 |
Long-Term Investments | - | - | - | 121.86 | 125.98 | - |
Goodwill | 445.87 | 465.25 | 435.88 | - | - | - |
Other Intangible Assets | 435.2 | 414.69 | 440.25 | 207.63 | 219.29 | 76.07 |
Long-Term Deferred Tax Assets | 35.19 | 28.3 | 22.93 | 19.53 | 10.38 | 13.65 |
Long-Term Deferred Charges | 172.53 | 202.78 | 185.98 | 173.99 | 97.42 | 78.7 |
Other Long-Term Assets | 9.1 | 15.6 | 54.64 | 22.63 | 21.87 | 9.4 |
Total Assets | 4,957 | 4,641 | 4,292 | 4,246 | 1,995 | 1,754 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 69.49 | 60.13 | 41.27 | 40.4 | 42.13 | 24.79 |
Accrued Expenses | 52.05 | 170.87 | 154.27 | 137.32 | 78.07 | 95.14 |
Short-Term Debt | - | - | 14 | - | - | - |
Current Portion of Leases | - | 10.61 | 12.89 | 11.38 | 9.09 | 8.84 |
Current Income Taxes Payable | 54.77 | 26.4 | 10.78 | 27.34 | 9.66 | 10.71 |
Current Unearned Revenue | 63.07 | 13.78 | 4.57 | 1.86 | 2.53 | 2.16 |
Other Current Liabilities | 301.91 | 127.45 | 101.26 | 94.47 | 45.36 | 20.4 |
Total Current Liabilities | 553.02 | 409.25 | 339.04 | 312.76 | 186.83 | 162.05 |
Long-Term Leases | 6.08 | 4.37 | 13.97 | 24.37 | 32.09 | 36.97 |
Long-Term Unearned Revenue | 71.51 | 75.56 | 59.1 | 37.88 | 27.25 | 24.61 |
Long-Term Deferred Tax Liabilities | 38.51 | 42.38 | 49.36 | - | - | - |
Other Long-Term Liabilities | 11.1 | 11.07 | 7.65 | 7.62 | 6.32 | 7.84 |
Total Liabilities | 680.21 | 542.63 | 469.13 | 382.63 | 252.49 | 231.47 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 123.26 | 123.26 | 123.26 | 82.73 | 71.98 | 71.98 |
Additional Paid-In Capital | 2,675 | 2,669 | 2,656 | 2,623 | 834.99 | 818.33 |
Retained Earnings | 1,712 | 1,510 | 1,147 | 1,137 | 809.71 | 603.98 |
Treasury Stock | -240.11 | -240.11 | -120 | - | - | - |
Comprehensive Income & Other | -12.02 | 13.13 | -13.71 | 1.59 | 1.99 | - |
Total Common Equity | 4,258 | 4,075 | 3,792 | 3,844 | 1,719 | 1,494 |
Minority Interest | 18.93 | 23.18 | 30.63 | 19.76 | 23.96 | 27.81 |
Shareholders' Equity | 4,276 | 4,099 | 3,822 | 3,864 | 1,743 | 1,522 |
Total Liabilities & Equity | 4,957 | 4,641 | 4,292 | 4,246 | 1,995 | 1,754 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.81 | 14.98 | 40.86 | 35.75 | 41.18 | 45.81 |
Net Cash (Debt) | 2,164 | 2,088 | 2,130 | 2,931 | 935.71 | 1,197 |
Net Cash Growth | -1.59% | -1.96% | -27.34% | 213.26% | -21.86% | 13.90% |
Net Cash Per Share | 18.06 | 17.24 | 17.26 | 27.21 | 8.73 | 11.17 |
Filing Date Shares Outstanding | 120.5 | 120.84 | 122.37 | 123.26 | 107.25 | 107.25 |
Total Common Shares Outstanding | 120.5 | 120.84 | 122.37 | 123.26 | 107.25 | 107.25 |
Working Capital | 2,442 | 2,393 | 2,401 | 3,052 | 1,108 | 1,297 |
Book Value Per Share | 35.33 | 33.72 | 30.99 | 31.18 | 16.03 | 13.93 |
Tangible Book Value | 3,376 | 3,195 | 2,916 | 3,636 | 1,499 | 1,418 |
Tangible Book Value Per Share | 28.02 | 26.44 | 23.83 | 29.50 | 13.98 | 13.22 |
Buildings | - | 49.51 | 49.79 | 50.05 | 48.34 | 45.97 |
Machinery | - | 144.87 | 138.16 | 99.48 | 80.2 | 58.67 |
Construction In Progress | - | 606.65 | 288.27 | 205.96 | 100.65 | 2.25 |